Fundraising FoxWoolseypharma
New York, US · Founded 2019 · 2 known investors
Find your way into Woolseypharma
Sign up to see every warm intro you have to Woolseypharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Woolseypharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Woolsey Pharmaceuticals Pty Ltd (Woolsey AU) is the Australian subsidiary of Woolsey Pharmaceuticals, Inc., leading the company's corporate research and development activities in Australia. It operates in the pharmaceutical and biotech sector.
Founders & leadership
DM
DAVID M. GELIEBTERNamed on SEC filing
SJ
SVEN JACOBSONNamed on SEC filing
JC
Julian CaplesLocal Director
Investors · 2
Reported raises · per SEC filings
Form D private placements$28.3M disclosed across 2 rounds · 2020–2021
▶$19.7MraisedOct 2021 · 41 investors · PharmaceuticalsRule 506(b)
▶$19.7MraisedOct 2021 · 41 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- SVEN JACOBSONExecutive Officer, Director
- DAVID M. GELIEBTERExecutive Officer, Director
- Amount sold
- $19.7M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$8.6MraisedApr 2020 · 54 investors · PharmaceuticalsRule 506(b)
▶$8.6MraisedApr 2020 · 54 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- DAVID M. GELIEBTERDirector
- SVEN JACOBSONExecutive Officer, Director
- Amount sold
- $8.6M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
C3 HealthcareRxC3 Healthcare Rx provides medication management services including in-home prescription delivery for poly-chronic patients, with programs aimed at improving adherence and reducing medication errors and hospital readmissions. It also offers virtual behavioral health programs for non-acute mental health and addiction through the Collaborative Care model.
Journey MedicalJourney Medical Corporation is a commercial-stage pharmaceutical company that develops and commercializes FDA-approved prescription treatments for dermatological conditions. It serves patients and healthcare professionals with a portfolio of therapies for common skin conditions and wound healing.
Companies working in the same space as Woolseypharma.
Frequently asked questions
- What does Woolseypharma do?
- Woolsey Pharmaceuticals Pty Ltd (Woolsey AU) is the Australian subsidiary of Woolsey Pharmaceuticals, Inc., leading the company's corporate research and development activities in Australia. It operates in the pharmaceutical and biotech sector.
- Who are Woolseypharma's investors?
- Woolseypharma's investors include Nelstone Ventures, New Ground Ventures.
- How much funding has Woolseypharma raised?
- Woolseypharma has disclosed $28.3M raised across 2 rounds.
- Where is Woolseypharma headquartered?
- Woolseypharma is headquartered in New York, US.